Drug Type Biosimilar, Monoclonal antibody |
Synonyms SBM 06, SBM06 |
Target- |
Action- |
Mechanism- |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhaseDiscovery |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Colorectal Cancer | Discovery | India | 01 Dec 2025 | |
| Hodgkin's Lymphoma | Discovery | India | 01 Dec 2025 | |
| Melanoma | Discovery | India | 01 Dec 2025 | |
| Mesothelioma | Discovery | India | 01 Dec 2025 | |
| Non-Small Cell Lung Cancer | Discovery | India | 01 Dec 2025 | |
| Renal Cell Carcinoma | Discovery | India | 01 Dec 2025 | |
| Squamous Cell Carcinoma of Head and Neck | Discovery | India | 01 Dec 2025 | |
| Transitional Cell Carcinoma | Discovery | India | 01 Dec 2025 |






